Delivery Order SPE2DB22D3016-SPE2DB25FAWC8

Award Date 5/12/25
Potential Completion Date 6/3/25
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ONIVYDE 43 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $10,691.34 and a performance period ending on May 9, 2025. The contract is a firm-fixed-price delivery order, and it is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ONIVYDE 43 MG/10 ML VIAL 10ML pharmaceutical products. The order has a potential value of $9,772.62 and a completion date of January 18, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used. This delivery order is part of Amerisourcebergen Drug Corp's broader support of DLA...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $15,168.60 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ONIVYDE 43 MG/10 ML VIAL 10ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The $8,427.00 firm-fixed price contract is for the supply of ONIVYDE 43 MG/10 ML VIAL 10ML, a pharmaceutical product, with a period of performance through May 28, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. government, particularly the Department of Defense (DoD) and Department of...
This federal contract award is for the pharmaceutical product ONIVYDE 43 MG/10 ML VIAL 10ML, with a ceiling value of $5,056.20. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 4, 2024 and is structured as a Firm Fixed Price Delivery Order. The award does not indicate any set-aside requirements,...
This federal contract award, valued at $10,112.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of ONIVYDE 43 MG/10 ML VIAL 10ML, a pharmaceutical product, and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025....
The Defense Logistics Agency awarded a $16,287.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ONIVYDE 43 MG/10 ML vials. The delivery order is to provide 10 mL vials of ONIVYDE, an oncology drug used to treat metastatic pancreatic cancer, to be delivered to a facility in Conshohocken, Pennsylvania by October 18, 2023. Amerisourcebergen will serve as the prime contractor to fulfill this order placed under an existing pharmaceutical supply vehicle. No subcontractors...
The Defense Logistics Agency Troop Support Medical awarded a $9,772.56 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4561784355 ONIVYDE 43 MG/10 ML VIAL 10ML. The place of performance is Conshohocken, Pennsylvania. The contract period runs from August 11, 2023 through September 1, 2023. The award is associated with the supply of ONIVYDE 43 MG/10 ML VIAL pharmaceutical products to support the Defense Logistics Agency Troop Support Medical's medical...
The Defense Logistics Agency awarded a $9,772.56 firm fixed price delivery order to Amerisourcebergen Drug Corp for 4561391421 ONIVYDE 43 MG/10 ML VIAL 10ML. Amerisourcebergen Drug Corp will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 24, 2023 under the contract. The prime contractor, Amerisourcebergen Drug Corp, is a division of Amerisourcebergen Corporation. No subcontractors or set aside designations were identified. The Defense Logistics Agency...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,631.26, is for the delivery of POLIVY 140 MG VIALS, a medical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAWC8
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ONIVYDE 43 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $5,345.67 and a performance period through June 3, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and the contract is a child award under the company's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC allows Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 8/17/25, 1:10 AM